Pregabalin augmentation to antidepressants in patients with major depressive disorder

  • Chi Un Pae

Research output: Contribution to journalLetterpeer-review

19 Scopus citations
Original languageEnglish
Pages (from-to)577-578
Number of pages2
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume33
Issue number3
DOIs
StatePublished - 30 Apr 2009

Bibliographical note

Funding Information:
This work was supported by a grant from the Medical Research Center, Korea Science and Engineering Foundation, Republic of Korea (R13-2002-005-04001-0).

Funding Information:
Dr. Pae has received research grant from GlaxoSmithKline Korea, GlaxoSmithKline, AstraZeneca Korea, Janssen Pharmaceuticals Korea, Eli Lilly and Company Korea, Korean Research Foundation, Otsuka Korea Pharmaceuticals, Wyeth Korea, Catholic Medical Center, and Korean Institute of Science and Technology Evaluation and Planning; has received honoraria and is on the speaker's bureaus of GlaxoSmithKline Korea, Lundbeck Korea, AstraZeneca Korea, Janssen Pharmaceuticals Korea, Eli Lilly and Company Korea, McNeil Consumer and Specialty Inc, and Otsuka Korea Pharmaceuticals, Inc.

Cite this